Diagnosis of Cardiac Lesions in Marfan Syndrome
Transthoracic echocardiography (TTE) is the primary and essential diagnostic tool for detecting cardiac lesions in Marfan syndrome, recommended at initial diagnosis to measure aortic root and ascending aorta diameters, with CT or MRI reserved for cases where TTE provides inadequate visualization. 1
Initial Diagnostic Approach
The 2022 ACC/AHA guidelines provide a Class 1 recommendation for TTE as the first-line imaging modality at the time of initial Marfan syndrome diagnosis 1. This approach prioritizes mortality reduction by identifying the most life-threatening cardiac manifestation: aortic root dilation, which leads to type A aortic dissection—the leading cause of death in Marfan syndrome.
What TTE Must Assess:
- Aortic root diameter at the sinuses of Valsalva (most critical measurement)
- Ascending aorta diameter and sinotubular junction
- Mitral valve for prolapse (present in 57-80% of patients) 2, 3, 4
- Aortic valve for regurgitation
- Left ventricular function
Key measurement threshold: Aortic root dilation is defined as ≥2 standard deviations above the mean for age, sex, and body surface area (Z-score >+2) 5. Use nomograms accounting for these variables—absolute measurements alone are insufficient, particularly in children and tall individuals.
When to Escalate Beyond TTE
If the aortic root or ascending aorta cannot be adequately visualized on TTE, CT or MRI of the thoracic aorta is recommended (Class 1) 1. This is not optional—inadequate visualization requires advanced imaging because:
- Chest wall deformities (pectus excavatum/carinatum) commonly limit TTE windows in Marfan patients 1
- Missing aortic pathology has fatal consequences
- Chest X-ray is unreliable—patients with aortic roots measuring 6.0-7.9 cm have shown no evident enlargement on plain films 4
Additional Imaging Considerations:
After initial TTE, CT or MRI of the thoracic aorta is reasonable (Class 2a) in adults to confirm aortic diameters and assess the entire thoracic aorta 1. This addresses the 10% of patients who present with type B dissection as their initial aortic event and evaluates descending aortic involvement.
Transoesophageal echocardiography (TEE) provides superior visualization when aortic dissection is suspected and can assess aortic root dimensions when TTE is inadequate 6. However, it is invasive and typically reserved for specific clinical scenarios rather than routine diagnosis.
Surveillance Algorithm After Diagnosis
The imaging frequency directly impacts mortality prevention:
- Repeat TTE at 6 months to determine rate of aortic growth 1
- If stable: Annual TTE surveillance 1
- If aortic diameter >4.5 cm or rapid growth (>0.5 cm/year): Every 6 months 5
- Post-aortic root replacement: Annual MRI or CT to evaluate for distal thoracic aortic disease 1
Critical Pitfalls to Avoid
- Do not rely on physical examination alone: Echocardiography detects abnormalities in 82% of patients versus only 52% by auscultation 4
- Do not use chest X-ray to exclude aortic root enlargement: It misses significant pathology even at life-threatening dimensions 4
- Do not underestimate left atrial size in patients with aortic root enlargement—anteroposterior compression by the dilated aorta causes underestimation 4
- Do not assume normal TTE excludes all cardiac involvement: While rare, some patients develop mitral valve disease that TTE may miss, particularly with left ventricular dilation 4
Why This Approach Prioritizes Mortality
Aortic root dilation and dissection cause the majority of deaths in Marfan syndrome 1. The mean aortic root growth is 1-1.5 mm over 3 years, with faster progression in larger aneurysms 1. Prophylactic aortic root replacement at ≥5.0 cm prevents type A dissection and improves survival 1. Early detection through systematic TTE surveillance enables timely surgical intervention before catastrophic dissection occurs.
The diagnostic strategy emphasizes TTE because it is non-invasive, radiation-free, widely available, and provides the essential measurements needed for surgical decision-making. Advanced imaging with CT/MRI serves as a complementary tool when TTE is limited or to evaluate the entire aorta, but should not delay or replace initial TTE assessment.